» Articles » PMID: 22802772

Analysis of the Brain Proton Magnetic Resonance Spectroscopy - Differences Between Normal Grey and White Matter

Overview
Journal Pol J Radiol
Publisher Termedia
Specialty Radiology
Date 2012 Jul 18
PMID 22802772
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The proton magnetic resonance spectroscopy (HMRS) is a non-invasive diagnostic method that allows for an assessment of the metabolite concentration in tissues. The sources of the strongest resonance signals within the brain are N-acetylaspartate (NAA), creatine (Cr), choline (Cho), myoinositol (mI) and water. The aim of our study was to analyse the ratios of metabolite signals within the brain in HMRS in the healthy population, to define the differences between the grey and white matter spectra.

Material/methods: We studied prospectively 90 subjects aged from 8 to 80 years (mean 43.3 years, SD=17.9), without neurological symptoms or abnormalities in magnetic resonance imaging. In all patients, brain HMRS with Signa HDx 1.5 T MR unit (GE Healthcare) was performed with PRESS sequence, using a single voxel method, at TE of 35 ms and TR of 1500 ms. Spectroscopic evaluation involved voxels placed in the white matter of parietal lobe (PWM) and the grey matter of posterior cingulate gyrus (PGM). On the basis of the intensity of NAA, Cr, Cho, mI and water signals, the proportions of these signals were calculated, as well as the ratio of the analyzed metabolite signal to the sum of signals of NAA, Cho, Cr and mI (%Met) in the PGM and PWM voxels. We compared the proportions in the same patients in PGM and PWM voxels.

Results: There has been a statistically significant difference between the proportions of a majority of the metabolite ratios evaluated in PGM and PWM, indicating the higher concentration of NAA, Cr and mI in grey matter, and higher concentration of Cho in white matter.

Conclusions: HMRS spectra of the brain grey and white matter differ significantly. The concentrations of NAA, Cr and mI are higher in grey matter, while of choline - in the white matter.

Citing Articles

Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.

Gronbaek-Thygesen M, Hartmann-Petersen R Cell Biosci. 2024; 14(1):45.

PMID: 38582917 PMC: 10998430. DOI: 10.1186/s13578-024-01224-6.


H-MRS neurometabolite profiles and motor development in school-aged children who are HIV-exposed uninfected: a birth cohort study.

Williams S, Robertson F, Wedderburn C, Ringshaw J, Bradford L, Nyakonda C Front Neurosci. 2023; 17:1251575.

PMID: 37901429 PMC: 10600451. DOI: 10.3389/fnins.2023.1251575.


An MR spectroscopy study of temporal areas excluding primary auditory cortex and frontal regions in subjective bilateral and unilateral tinnitus.

Wojcik J, Kochanski B, Ciesla K, Lewandowska M, Karpiesz L, Niedzialek I Sci Rep. 2023; 13(1):18417.

PMID: 37891242 PMC: 10611771. DOI: 10.1038/s41598-023-45024-3.


sLASER and PRESS perform similarly at revealing metabolite-age correlations at 3 T.

Hui S, Zollner H, Gong T, Hupfeld K, Gudmundson A, Murali-Manohar S Magn Reson Med. 2023; 91(2):431-442.

PMID: 37876339 PMC: 10942734. DOI: 10.1002/mrm.29895.


Thalamic neurometabolite alterations in chronic low back pain: a common phenomenon across musculoskeletal pain conditions?.

Weerasekera A, Knight P, Alshelh Z, Morrissey E, Kim M, Zhang Y Pain. 2023; 165(1):126-134.

PMID: 37578456 PMC: 10841327. DOI: 10.1097/j.pain.0000000000003002.


References
1.
Pouwels P, Frahm J . Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med. 1998; 39(1):53-60. DOI: 10.1002/mrm.1910390110. View

2.
van der Graaf M . In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2009; 39(4):527-40. PMC: 2841275. DOI: 10.1007/s00249-009-0517-y. View

3.
Noworolski S, Nelson S, Henry R, Day M, Wald L, Star-Lack J . High spatial resolution 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med. 1999; 41(1):21-9. DOI: 10.1002/(sici)1522-2594(199901)41:1<21::aid-mrm5>3.0.co;2-v. View

4.
Angelie E, Bonmartin A, Boudraa A, Gonnaud P, Mallet J, Sappey-Marinier D . Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am J Neuroradiol. 2001; 22(1):119-27. PMC: 7975557. View

5.
Pattany P, Massand M, Bowen B, Quencer R . Quantitative analysis of the effects of physiologic brain motion on point-resolved spectroscopy. AJNR Am J Neuroradiol. 2006; 27(5):1070-3. PMC: 7975735. View